Related Experiment Videos
Prevention of central venous catheter-associated thrombosis: a meta-analysis
Angelia Kirkpatrick1, Suman Rathbun, Thomas Whitsett
1Department of Medicine, Cardiovascular Section, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. akirkpat@ouhsc.edu
Insights
Anticoagulant prophylaxis effectively prevents all catheter-associated deep vein thrombosis in patients with central venous catheters. However, its benefit for symptomatic venous thromboembolism remains uncertain.
Area of Science:
- Vascular Medicine
- Pharmacology
- Clinical Trials
Background:
- Central venous catheters are essential but increase deep vein thrombosis (DVT) risk.
- Prophylaxis with anticoagulants is debated for catheter-associated DVT.
Purpose of the Study:
- To evaluate the efficacy of anticoagulant prophylaxis in preventing DVT in patients with central venous catheters.
- To synthesize evidence from randomized controlled trials (RCTs).
Main Methods:
- Meta-analysis of 15 randomized controlled trials.
- Searched MEDLINE, EMBASE, conference proceedings, and bibliographies up to May 2006.
- Evaluated unfractionated heparin, vitamin K antagonists, and low-molecular-weight heparin.
Main Results:
- Anticoagulant prophylaxis significantly reduced all catheter-associated DVTs (relative risks 0.31-0.73).
- Significant reduction was observed for symptomatic and asymptomatic DVTs combined.
- Effectiveness for symptomatic DVT alone did not reach statistical significance for individual regimens.
Conclusions:
- Anticoagulant prophylaxis is effective in preventing all catheter-associated DVTs.
- The role of prophylaxis in preventing symptomatic venous thromboembolism, including pulmonary embolism, requires further investigation.
Purpose:
Anticoagulant prophylaxis in patients with central venous catheters is controversial. We performed a meta-analysis of randomized controlled trials of anticoagulant prophylaxis in patients with central venous catheters.
Methods:
MEDLINE and EMBASE were searched up to May 2006, supplemented by manual searches of conference proceedings and bibliographies.
Results:
Fifteen trials were included. Unfractionated heparin infusion, oral fixed low-dose vitamin K antagonist, and subcutaneous low-molecular-weight heparin were evaluated. For all catheter-associated deep vein thrombosis (symptomatic and asymptomatic combined), the summary relative risks ranged from 0.31 to 0.73 (all achieved statistical significance). For symptomatic deep vein thrombosis, the summary relative risks ranged from 0.28 to 0.72, but did not achieve statistical significance for any individual regimen.
Conclusion:
Anticoagulant prophylaxis is effective for preventing all catheter-associated deep vein thrombosis in patients with central venous catheters. The effectiveness for preventing symptomatic venous thromboembolism, including pulmonary embolism, remains uncertain.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...